Metoprolol Succinate recalls

Metoprolol Succinate products have been recalled 10 times, most recently on 11 Mar 2026. The recalling company is usually Teva Pharmaceuticals USA. The most common reason is potency & assay.

Total recalls10since 2014

Last 12 months4reported

Class I00% of total

Ongoing4latest 11 Mar 2026

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 4Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 10 100%Class III 0 0%

Why metoprolol succinate is recalled

Companies

Product types

Blood Pressure Medication10100%

By year

2026440%
2024110%
2023110%
2022110%
2018110%
2014220%

Ongoing metoprolol succinate recalls

4 active

Reported	Class	Recall	Company	Reason	Where
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 200 mg recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 25 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 50 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide

All metoprolol succinate recalls, newest first

10 total

Reported	Class	Recall	Company	Reason	Where
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 200 mg recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 25 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
11 Mar 2026Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, 50 mg bottles recalledMetoprolol Succinate	Teva Pharmaceuticals USA	Potency & Assay	Nationwide
3 Jan 2024Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP, 50 mg recalledMetoprolol Succinate	Cardinal Healthcare	Manufacturing (CGMP) Deviations	Nationwide
22 Feb 2023Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP, 50 mg recalledMetoprolol Succinate	Amerisource Health Services	Potency & Assay	Nationwide
2 Feb 2022Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP 50 mg recalledMetoprolol Succinate	American Health Packaging	Potency & Assay	Nationwide
16 May 2018Drug	CLASS II	Metoprolol Succinate Extended-Release Tablets, USP, 100 mg recalledMetoprolol Succinate	Dr. Reddy's Laboratories	Other	Nationwide
18 Jun 2014Drug	CLASS II	Dr. Reddy's Metoprolol Succinate Extended Release Tablets, USP 25 mg recalledMetoprolol Succinate	Dr. Reddy's Laboratories	Potency & Assay	Nationwide
12 Feb 2014Drug	CLASS II	Dr. Reddy's Metoprolol Succinate Extended-Release Tablets USP, 50 mg recalledMetoprolol Succinate	Dr. Reddy's Laboratories	Potency & Assay	5 states

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.